Something for your future self
Cervical cancer is the third most common malignancy in women worldwide, and it remains a leading cause of cancer-related death for women in developing countries.
Signs and symptoms
The most common finding in patients with cervical cancer is an abnormal Papanicolaou (Pap) test result.
Physical symptoms of cervical cancer may include the following:
- Abnormal vaginal bleeding
- Vaginal discomfort
- Malodorous discharge
Human Papilloma Virus (HPV) infection must be present for cervical cancer to occur. Complete evaluation starts with Papanicolaou (Pap) testing.
The HPV genotype test is a useful test to evaluate your risk of being infected by the HPV virus and the genotype of the virus. Those who are infected with the higher risk genotype like HPV 16 and 18 are at a higher risk of cervical cancer and have to be screened more regularly with PAP smear. The HPV genotype test can be performed on both females and males as HPV can cause cervical warts and cancer in females and genital warts and genital cancer in males.
Neo-Health offers the HPV genotype testing and with our continuous innovation in lab technology, we are now able to increase the spectrum of genotype being tested from 21 to 37 genotypes. This will offer the patients a wider coverage of detection and greater protection.
Evidence suggests that HPV vaccines prevent HPV infection. The following 2 HPV vaccines are approved by the FDA:
- Gardasil: This quadrivalent vaccine is approved for females to prevent cervical cancer (and also genital warts and anal cancer) caused by HPV types 6, 11, 16, and 18; it is also approved for males.
- Cervarix: This bivalent vaccine is approved for females to prevent cervical cancer caused by HPV types 16 and 18.
Protect yourself against cervical cancer and genital warts. Give us a call to find out more about our special 3-dose promotion today.